Conference Coverage

Rheumatoid arthritis increases heart failure risk


 

AT THE ESC CONGRESS 2016

ROME– Rheumatoid arthritis is associated with a significantly increased risk of hospitalization for heart failure, according to a nationwide Danish study, Usman Khalid, MD, reported at the annual congress of the European Society of Cardiology.

Dr. Usman Khalid

Dr. Usman Khalid

Using these tools, he identified 13,800 Danish adults with RA and no history of heart failure hospitalization as of Jan. 1, 1997. They were followed for 15 years thereafter and compared with the 5,584,420 Danish adults without RA. The incidence rate for heart failure hospitalization in the general population was 2.45/1,000 person-years, compared with 7.37/1,000 in the RA cohort.

In an analysis adjusted for age, sex, and calendar year, individuals with RA were 83% more likely to be hospitalized for heart failure than were the non-RA Danish population. In a fully adjusted analysis that controlled for those potential confounders as well as comorbid conditions, smoking, alcohol intake, socioeconomic status, and prescription medications, patients with RA remained at a statistically significant and clinically meaningful 38% increased risk of heart failure hospitalization.

Further studies are planned to determine the underlying mechanisms of this association, Dr. Khalid added.

He reported having no financial conflicts of interest regarding this study, which was supported by an unrestricted grant from Leo Pharma.

Recommended Reading

VIDEO: Consider immunogenicity when choosing biologics
MDedge Rheumatology
VIDEO: Get comfortable with screening for, treating CVD risk in RA
MDedge Rheumatology
Most children with JIA get different diagnosis as adults
MDedge Rheumatology
Be vigilant for restrictive lung disease in RA
MDedge Rheumatology
RA prevention trials seek to stop clinical onset of disease
MDedge Rheumatology
Severe joint pain in adults with arthritis continues to rise
MDedge Rheumatology
Birth outcomes unaffected by paternal immunosuppressive therapy
MDedge Rheumatology
Silicone joint arthroplasty for RA shows sustained improvements at 7 years
MDedge Rheumatology
FDA approves biosimilar adalimumab
MDedge Rheumatology
Unexplained subfertility in RA linked to periconceptional NSAID use
MDedge Rheumatology